Check Cap Ltd is an Israel-based clinical-stage medical diagnostics company. Check Cap Ltd develops C-Scan, patient-friendly preparation-free test designed to detect polyps before they may transform into cancer to enable early intervention and cancer prevention. It's capsule-based screening technology aims to increase screening adherence worldwide. The system utilizes ultra-low-dose X- rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities. C-Scan is non-invasive capsule that is propelled through the gastrointestinal tract by natural motility. C-Scan is comprised of three main components: C-Scan Cap, an ingestible X-ray scanning capsule; C-Scan Track, three miniaturized patches worn on the patient’s back for integrated positioning, control and data recording; and C-Scan View, a proprietary software to process and represent 2D and 3D maps of the inner surface of the colon.
종목 코드 CHEK
회사 이름Check Cap Ltd
상장일Feb 19, 2015
CEOOvadia (Alex)
직원 수- -
유형Ordinary Share
회계 연도 종료Feb 19
주소29 Abba Hushi Ave.
도시
증권 거래소NASDAQ OMX - NASDAQ BASIC
국가Israel
우편 번호3009000
전화97248303401
웹사이트https://check-cap.com/
종목 코드 CHEK
상장일Feb 19, 2015
CEOOvadia (Alex)
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.

데이터 없음